Recursion Pharmaceuticals SG&A Expense (TTM) Analysis

Recursion Pharmaceuticals Inc (RXRX)

7.16 -0.30 (-4.02%) USD | NASDAQ | Jul 02, 16:00

7.24 +0.08 (+1.12%) After-Hours: 06:18

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	119.36M
December 31, 2023	110.82M
September 30, 2023	100.20M
June 30, 2023	90.49M
March 31, 2023	83.40M
December 31, 2022	81.60M
September 30, 2022	80.96M

Date	Value
June 30, 2022	77.16M
March 31, 2022	69.82M
December 31, 2021	57.68M
September 30, 2021	46.06M
June 30, 2021	37.33M
March 31, 2021	28.63M
December 31, 2020	25.26M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

25.26M

Minimum

Dec 2020

119.36M

Maximum

Mar 2024

72.05M

Average

79.06M

Median

SG&A Expense (TTM) Benchmarks